These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16077365)

  • 41. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
    Degenring RF; Kamppeter B; Kreissig I; Jonas JB
    Acta Ophthalmol Scand; 2003 Oct; 81(5):548-50. PubMed ID: 14510813
    [No Abstract]   [Full Text] [Related]  

  • 42. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
    Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O
    Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
    Degenring RF; Kamppeter B; Kreissig I; Jonas JB
    Acta Ophthalmol Scand; 2003 Aug; 81(4):399-401. PubMed ID: 12859269
    [No Abstract]   [Full Text] [Related]  

  • 44. Highly reflective line in optical coherence tomography images of eyes with macular edema associated with branch retinal vein occlusion.
    Hasegawa T; Masuda N; Ogata N
    Am J Ophthalmol; 2015 May; 159(5):925-33.e1. PubMed ID: 25644536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
    Moon J; Kim M; Sagong M
    Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone.
    Scorolli L; Morara M; Meduri A; Reggiani LB; Ferreri G; Scalinci SZ; Meduri RA
    Arch Ophthalmol; 2007 Jun; 125(6):759-64. PubMed ID: 17562986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion.
    Ozdek SC; Aydin B; Gürelik G; Bahçeci U; Hasanreisoğlu B
    Int Ophthalmol; 2005; 26(1-2):27-34. PubMed ID: 16783483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
    Chen SD; Sundaram V; Lochhead J; Patel CK
    Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal triamcinolone for ischemic branch retinal vein occlusion with serous retinal detachment.
    Prasad AG; Shah GK
    Retina; 2006 Feb; 26(2):234-6. PubMed ID: 16467689
    [No Abstract]   [Full Text] [Related]  

  • 50. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy.
    Martidis A; Duker JS; Puliafito CA
    Arch Ophthalmol; 2001 Sep; 119(9):1380-3. PubMed ID: 11545651
    [No Abstract]   [Full Text] [Related]  

  • 51. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
    Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
    Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection.
    Hirasawa M; Noda K; Shinoda H; Ozawa Y; Tsubota K; Ishida S
    Jpn J Ophthalmol; 2009 May; 53(3):279-81. PubMed ID: 19484453
    [No Abstract]   [Full Text] [Related]  

  • 53. Steroids for branch retinal vein occlusion.
    Kaiser PK
    Am J Ophthalmol; 2005 Jun; 139(6):1095-6. PubMed ID: 15953443
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Bobbili RB; Mathai A
    Am J Ophthalmol; 2006 Sep; 142(3):531; author reply 531-2. PubMed ID: 16935620
    [No Abstract]   [Full Text] [Related]  

  • 55. Intravitreal steroids in the management of macular oedema.
    Sivaprasad S; McCluskey P; Lightman S
    Acta Ophthalmol Scand; 2006 Dec; 84(6):722-33. PubMed ID: 17083528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion.
    Ehlers JP; Fekrat S
    Can J Ophthalmol; 2011 Feb; 46(1):88-9. PubMed ID: 21283167
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of bevacizumab and triamcinolone for treatment of macular edema secondary to branch retinal vein occlusion in a pair-matched analysis.
    Guthoff R; Meigen T; Hennemann K; Schrader W
    Ophthalmologica; 2010; 224(5):319-24. PubMed ID: 20424494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal triamcinolone for refractory pseudophakic macular edema.
    Benhamou N; Massin P; Haouchine B; Audren F; Tadayoni R; Gaudric A
    Am J Ophthalmol; 2003 Feb; 135(2):246-9. PubMed ID: 12566041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
    Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
    Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.